Clinical trial
Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet
NCT01073631 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2006
- Completion date
- October 31, 2009
- Enrollment
- 543 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
serious fungal infections